Humanized Mouse Models for Immuno-oncology Drug Discovery

Area of Science:

• Immuno-oncology
• Translational research
• Preclinical drug development

Background:

• Immunotherapeutics offer long-term cancer patient benefits, but response rates vary, and resistance mechanisms remain unclear.
• Effective preclinical models are essential for understanding the tumor microenvironment and screening novel cancer treatments.
• Humanized mice, incorporating human tumors and immune cells, are valuable tools in immuno-oncology research.

Purpose of the Study:

• To review recent advancements in humanized mouse models for immuno-oncology drug discovery.
• To discuss the benefits and drawbacks of these models in cancer research.
• To explore their application in evaluating immunotherapeutic efficacy and safety.

Main Methods:

• Overview of humanized mouse models, including human tumor and immune cell engraftment.
• Discussion of model improvements focusing on humanization and translational relevance.
• Analysis of applications in efficacy and safety/toxicity assessments of immunotherapeutics.

Main Results:

• Humanized models offer a more comprehensive recapitulation of the human tumor microenvironment.
• These models facilitate the study of complex interactions within the cancer-immunity cycle.
• Recent developments enhance the translational value of humanized mice for drug discovery.

Conclusions:

• Humanized mouse models are pivotal for advancing immuno-oncology drug discovery.
• Continued development of these models is key to overcoming challenges in cancer treatment.
• They provide critical insights for the efficacy and safety evaluation of novel immunotherapeutics.